Inbio Ventures

Inbio Ventures is a Moscow, Russia-based venture capital firm specializing in early-stage investments in biotech startups. The firm manages $300 million in assets under management and has deployed over $200 million across its portfolio, typically making investment tickets ranging from $1 million to $5 million. It leverages deep sector expertise, drawing from backgrounds in academia, industrial R&D, corporate venture capital, business development, and public equities asset management, to identify promising opportunities. Its portfolio includes recognized companies such as Pharmstandard, Generium, Aquinox, Protagonist, and Allena. Inbio Ventures focuses on venture capital investments and strategic deals within the life sciences sector. Founded in 2013. The firm focuses on biotech sector, with investments in companies like Pharmstandard, Generium, Aquinox, Protagonist, Codon, Allena, and Transmedics.